Creates dynamic and thought-provoking lessons.
This comment is not public.
Davin Quinn, MD, is a tenured Professor of Psychiatry in the Department of Psychiatry and Behavioral Sciences at the University of New Mexico School of Medicine. He holds multiple leadership roles, including Vice Chair for Adult Clinical Services, Chief of the Division of Behavioral Health Consultation and Integration, and Division Chief for Psychiatric Neuromodulation. He also serves as an attending physician on the Electroconvulsive Therapy service. Quinn earned a B.A. in Psychology from Princeton University in 1998 and an M.D. from Harvard Medical School in 2004, followed by a four-year residency in psychiatry at Massachusetts General Hospital and McLean Hospital. Joining the University of New Mexico faculty in 2009 after fellowship training at Massachusetts General Hospital, he served as medical director of the University of New Mexico Hospital Psychiatric Consultation Service, overseeing a near-doubling of service volume. Board-certified in adult psychiatry and consultation-liaison psychiatry, he became board-certified in behavioral neurology and neuropsychiatry in 2012 and in brain injury medicine in 2016. Quinn founded the UNM/New Mexico VA Health Care System Fellowship in Psychosomatic Medicine, which has graduated seven consultation-liaison psychiatrists, and established a traumatic brain injury clinic. In 2017, he launched the UNM Transcranial Magnetic Stimulation service and currently serves as principal investigator for two multi-center Department of Defense-funded randomized controlled trials, NAVIGATE-TBI and CONNECT-TBI, evaluating neuromodulation therapies for traumatic brain injury in U.S. Veterans and Servicemembers. His research focuses on the cognitive, emotional, and behavioral manifestations of neurologic diseases and traumatic brain injury; diagnosis and treatment of major depressive disorder in diverse populations; and the safe and effective use of neuromodulation therapies for psychiatric symptoms. Quinn leads four studies under the $5.9 million PRE-EMPT initiative, funded by the Department of Defense, investigating precision phenotyping to predict and prevent suicidal ideation in Veterans using transcranial magnetic stimulation, functional magnetic resonance imaging neurofeedback, psilocybin-assisted therapy, and artificial intelligence-driven multimodal data analysis.
Quinn has received numerous awards, including Fellow of the Academy of Consultation-Liaison Psychiatry in 2020, the Academy of Consultation-Liaison Psychiatry Visiting Professorship Program in 2022-2023, multiple teaching awards from the UNM Department of Psychiatry and Behavioral Sciences (2014-2017), Alpha Omega Alpha honor from UNM School of Medicine in 2012, the Thomas P. Hackett Award and Anne Alonso Award from MGH/McLean in 2008, and Albuquerque The Magazine Top Doc recognition from 2013-2016. Key publications include Mayer AR and Quinn DK, 'Neuroimaging biomarkers of new-onset psychiatric disorders following traumatic brain injury' (Biological Psychiatry, 2022); Quinn DK et al., 'Transcranial direct current stimulation modulates working memory and prefrontal-insula connectivity after mild-moderate traumatic brain injury' (Frontiers in Human Neuroscience, 2022); and Quinn DK et al., 'Right prefrontal intermittent theta-burst stimulation for major depressive disorder: a case series' (Brain Stimulation, 2021).
